Who Can Legally Operate
Pennsylvania does not use a single vertically-integrated license like Florida's MMTC model, nor New Jersey's six-class system. Act 16 instead separates cultivation/processing from retail dispensing into two distinct permit types, plus a third category tied to clinical research.
| License | Model | What You Can Do | Key Limit |
|---|---|---|---|
| Grower/Processor | Cultivation & processing only | Cultivate and process medical marijuana; sell wholesale to dispensaries — cannot dispense directly to patients | Capped at 25 permits statewide; no more than 5 of the 25 may simultaneously hold a dispensary permit |
| Dispensary | Retail only | Purchase from grower/processors and dispense to registered patients/caregivers | Capped at 50 permits; each permit covers up to 3 physical dispensing locations |
| Clinical Registrant | Combined research + commercial | Operate up to 6 locations; must maintain an active contractual relationship with an Approved Clinical Research Center (ACRC); may additionally hold one Grower/Processor and one Dispensary permit each | Capped at 10 statewide, counted separately from (in addition to) the base 25/50 caps |
As of 2026, PA DOH reports 192 operational dispensaries statewide, drawn from the 50-permit cap (each covering up to 3 locations), alongside the 25 grower/processor permits and up to 10 clinical registrants. The program has surpassed $9.1 billion in cumulative sales since 2018, with roughly 1,920 approved practitioners and an estimated 438,000–440,000 active patient certifications. Confirm current permit-holder rosters directly with DOH before relying on these figures for site-selection or M&A purposes.
PA DOH — pa.gov/agencies/health; The Marijuana Herald (May 2026 sales milestone); pennsylvaniastatecannabis.org statistics — Verified June 17, 2026.
License Application & Approval Process
Pennsylvania's three permit caps were largely filled during two initial application phases (2017–2018); openings since then have come from forfeited, revoked, or newly authorized permits rather than a rolling open-enrollment window. Outside of an open DOH application window, your near-term options are acquiring an existing permit holder through DOH's change-in-ownership process (not a permit transfer — permits cannot be transferred), or pursuing the Clinical Registrant track if you have an ACRC relationship.
| Fee | Amount | Notes |
|---|---|---|
| Grower/Processor application fee | $10,000 | Non-refundable; due with application |
| Grower/Processor initial permit fee | $200,000 | Refundable if the permit is not granted or the application is rejected |
| Grower/Processor renewal fee | $10,000 | Refundable if renewal is not granted |
| Dispensary application fee | $5,000 | Non-refundable; due with application |
| Dispensary permit fee | $30,000 / location | Charged per physical location at time of application; refundable if not granted |
| Dispensary renewal fee | $5,000 | Covers all locations under the permit at renewal — unlike the initial per-location fee |
| Change-in-ownership filing fee | $250 | Required for any addition/removal of a principal, operator, or financial backer, or a change of control |
| Patient/caregiver DOH ID card | $50 / year | Free for Medicaid, PACE/PACENET, CHIP, SNAP, and WIC enrollees |
Permit applications must include a diversity plan establishing goals for equal opportunity and access in employment and contracting, covering diverse racial/ethnic/cultural backgrounds, women, veterans, individuals with disabilities, and third-party-certified disadvantaged/minority/women-owned businesses. Diversity-plan performance is worth roughly 10% of total evaluation points (up to 100 points on the Grower/Processor scorecard) — a meaningful scoring lever, though Pennsylvania does not operate a dedicated equity license set-aside comparable to some other states in this series.
| Stage | What Happens | Timeline |
|---|---|---|
| 1. Application Window | DOH publishes a defined window when new permits become available (historically the 2017–2018 phased rollout; since then, forfeited/revoked-permit openings) | Irregular — not annual or rolling |
| 2. Submission | Operating plan, security plan, financials, diversity plan, and fingerprint-based background-check authorization for all principals/operators/financial backers | Fixed window |
| 3. DOH Scoring | Competitive scoring across statutory categories, including the diversity plan | Months |
| 4. Permit Award | DOH issues permits to top-scoring applicants | — |
| 5. Facility Build-Out & Inspection | DOH inspects for security, recordkeeping, and electronic tracking system (ETS) connectivity before authorizing operations | Months post-award |
| 6. Operations Begin | Permit holder may begin cultivating/processing or dispensing | — |
PA DOH permit fee schedule; Pennsylvania Bulletin (change-in-ownership rule); 28 Pa. Code §1141a.32 (diversity goals) — Verified June 17, 2026.
Ownership & Control Rules
All principals, financial backers, and operators of a Pennsylvania medical marijuana organization (MMO) must be fingerprinted and undergo a Pennsylvania State Police/FBI criminal history background check under 28 Pa. Code §1141a.31. A principal or financial backer may not be affiliated with an MMO if convicted of a felony relating to the manufacture, delivery, or possession with intent to manufacture or deliver a controlled substance — unless at least 10 years have passed since the conviction, or 1 year has passed since release from imprisonment, whichever is later.
Available sources do not identify a Pennsylvania-residency requirement for MMO principals or owners (distinct from patients and caregivers, who must be PA residents) — multistate operators hold a substantial share of current PA permits.
A "change in ownership" — adding or removing a principal, operator, or financial backer, or any change of control — requires a DOH application and a $250 fee. Notably, DOH does not approve the underlying equity transaction itself; it only approves the suitability of the individuals affiliating with the MMO going forward. Permits are not transferable to another person or to another location under any circumstance.
28 Pa. Code §1141a.31; Pennsylvania Bulletin change-in-ownership rule — Verified June 17, 2026.
What You Can Legally Sell
Pennsylvania does not run a two-tier low-THC/full-marijuana certification system like Florida's. Any approved product form is available to any qualifying patient holding a current practitioner certification — the limiting factor is product form and method of administration, not THC content.
- Pills
- Oils
- Topicals
- Tinctures
- Liquids
- Dry leaf/plant ("flower") — vaporization or nebulizer only
- 30-day supply per patient, individualized by practitioner certification and product form — no single fixed ounce cap
- Smoking (igniting and inhaling) is prohibited statewide — dry leaf/plant material must be administered via vaporizer or nebulizer only, per 28 Pa. Code §1151a.28
- Dry-leaf flower sales began in 2018
- Practitioner certifications are renewed periodically; a temporary telehealth-certification allowance is currently in place, with a 2025–2026 legislative push to make it permanent
Qualifying conditions include: anxiety disorders, ALS, autism, cancer, Crohn's disease, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, dyskinetic and spastic movement disorders, epilepsy, glaucoma, HIV/AIDS, Huntington's disease, inflammatory bowel disease, intractable seizures, multiple sclerosis, neurodegenerative diseases, neuropathies, opioid use disorder, Parkinson's disease, PTSD, severe chronic or intractable pain, sickle cell anemia, terminal illness, and Tourette syndrome — 23 distinct conditions in DOH's current enumerated list. (Some secondary sources round this to "24"; confirm the current text of 35 P.S. §10231.103 directly with DOH before relying on an exact count.)
35 P.S. §10231.103; 28 Pa. Code §1151a.28 — Verified June 17, 2026.
Where You Can Legally Operate
Pennsylvania gives municipalities meaningfully less zoning leverage than Florida's ban-or-parity choice. Municipalities must have zoning regulations in place for each MMO activity type before DOH will consider an application sited there, and many require special-exception approval through the local Zoning Hearing Board. But — unlike Florida — Pennsylvania courts have held that an ordinance banning MMOs outright, or one so restrictive that it amounts to a de facto ban, is unconstitutional. Municipalities cannot zone MMOs out of existence entirely.
| Local Governments CAN | Local Governments CANNOT |
|---|---|
| Apply standard commercial zoning to dispensaries and grower/processor facilities | Ban MMOs outright within their jurisdiction — held unconstitutional by PA courts |
| Require special-exception approval via the local Zoning Hearing Board | Adopt zoning so restrictive it amounts to a de facto ban |
| Require evidence of zoning compliance as part of the DOH permit application | Charge cannabis-specific local taxes (no PA locality may impose one) |
| Apply normal local business licensing/registration requirements | Override DOH's statewide permitting authority |
Confirm with the specific municipality whether it has adopted special-exception zoning, a parcel-specific overlay district, or simply applies its standard commercial-use rules — this varies significantly and, unlike a market with a statewide opt-in map, isn't centrally tracked. Build in time for a Zoning Hearing Board process if your target municipality requires special-exception approval.
Babst Calland zoning analysis; Chester County Planning Commission eTools; 28 Pa. Code Ch. 1141a — Verified June 17, 2026.
What Patients Can Legally Do
Pennsylvania has no adult-use consumer market — every purchase, possession, and consumption rule below applies only to registered patients and caregivers. Non-patients remain subject to ordinary Pennsylvania criminal law for any cannabis possession.
| Activity | Rule | Consequence if Violated |
|---|---|---|
| Patient ID card | $50/year fee (free for Medicaid, PACE/PACENET, CHIP, SNAP, WIC enrollees); valid practitioner certification required | No card = no legal purchase or possession under the program |
| Caregiver registration | $50/year fee; state-conducted background check at no extra cost; a patient may designate up to 2 caregivers; a caregiver may serve up to 5 patients | Unregistered caregiver activity falls outside program protection |
| Possession limit | 30-day supply, individualized by practitioner certification and product form — no single fixed ounce cap | Over the certified supply = unlawful possession under 35 P.S. §780-113 |
| Method of administration — dry leaf | Must be vaporized or administered via nebulizer; smoking (combustion) is prohibited statewide | Compliance violation; potential criminal exposure for unlawful manner of use |
| Home cultivation | NOT permitted — SB 76 (introduced Jan 22, 2025) would create a limited home-grow right for patients 21+; remains pending, not enacted | Unlicensed cultivation; criminal charge under §780-113 |
| Telehealth certification | Currently allowed under a temporary framework; a 2025–2026 legislative push seeks to make telehealth certification/renewal permanent | — |
| Sales tax | Medical marijuana purchased with a valid ID card at a DOH-licensed dispensary is exempt from PA's 6% state sales tax | — |
| Public consumption | Prohibited in any public place | Civil/criminal exposure under general public-consumption law |
PA DOH patient/caregiver program pages; 35 P.S. §10231.303; mmj.com caregiver guidance — Verified June 17, 2026.
Tax Obligations
Pennsylvania took a different — and earlier — path than almost every other state in this series. Governor Shapiro signed Senate Bill 1501 on October 29, 2024, amending the PA Tax Reform Code to let medical marijuana organizations take a subtraction modification on their Pennsylvania Corporate Net Income Tax (CNIT) return for ordinary business expenses that IRC §280E disallows federally. That state-level fix was locked in more than a year before the federal government acted.
Federal rule change, effective April 22, 2026: a DOJ/DEA final order separately moved marijuana sold under a qualifying state-licensed medical marijuana program from Schedule I to Schedule III of the Controlled Substances Act. Because §280E's expense-disallowance rule only applies to Schedule I/II substances, federal §280E no longer applies to Pennsylvania MMO revenue and COGS at all as of that date. (One Pennsylvania-specific industry source reported an April 28, 2026 effective date; April 22, 2026 is used consistently across this report series and should be treated as the controlling date absent further confirmation directly from DOJ/DEA's published order.)
Because Pennsylvania has no adult-use program, there is no Schedule-I/Schedule-III revenue-splitting problem here — the federal relief applies cleanly to 100% of MMO revenue, the same clean-outcome pattern seen in Florida.
Net effect: Pennsylvania MMOs now have both a state-level 280E fix (since Oct. 29, 2024) and a federal-level fix (since Apr. 22, 2026) — reached independently, on different timelines, through different mechanisms. Few states in this series have full relief on both fronts simultaneously.
What you should do: Confirm with a cannabis-experienced CPA that your PA CNIT return correctly claims the SB 1501 subtraction modification for all tax years since October 29, 2024 (including any amended-return opportunity for 2024), and confirm your federal return reflects full ordinary-expense deductibility for tax periods on or after April 22, 2026.
| Tax / Fee | Rate | Paid By | Notes |
|---|---|---|---|
| State Sales Tax — medical marijuana | 0% | Patient (exempt) | Exempt for ID-cardholder purchases at a DOH-licensed dispensary |
| Wholesale excise tax | 5% | Grower/Processor | On gross receipts from wholesale sale of medical marijuana to a dispensary — a B2B tax, not consumer-facing |
| Local cannabis excise tax | None | — | No Pennsylvania locality may impose a cannabis-specific tax |
| PA Corporate Net Income Tax (CNIT) | 7.49% | MMO (C-corp entity) | 2026 rate; phasing down 0.5 pts/year to 4.99% by 2031 under Act 53 of 2022. SB 1501 subtraction modification available since Oct. 29, 2024. |
| PA Personal Income Tax (pass-through owners) | 3.07% flat | Individual owners | Applies to MMOs organized as pass-through entities (LLC/S-corp) flowing income to owners' PA returns |
| Federal 280E | No longer applies Eff. Apr 22, 2026 | MMO (federal) | Schedule III reclassification removes 280E for PA's 100%-medical program revenue/COGS — no adult-use carve-out problem exists in Pennsylvania |
PA Dept. of Revenue; SB 1501 (signed Oct. 29, 2024); McNees Wallace 2026 PA tax-changes summary; Tax Foundation PA CNIT analysis; DOJ/DEA Schedule III order analyses — Verified June 17, 2026.
Ongoing Compliance Obligations
Pennsylvania's three-permit-type structure means compliance obligations differ by license: grower/processors and dispensaries each answer to DOH separately, while clinical registrants carry the added burden of maintaining their ACRC research relationship.
| Area | Requirement |
|---|---|
| DOH inspections | Facilities subject to both announced and unannounced inspection at any operating location |
| Diversity plan reporting | MMOs must report ongoing performance against their permit application's diversity plan goals |
| Practitioner certification verification | Dispensary staff must verify each patient's certification is current before dispensing |
| Advertising pre-approval | All promotional/marketing materials require DOH pre-approval before use under 28 Pa. Code §1141a.50 |
| Record retention | Financial, operational, and patient-transaction records must be retained and available for DOH inspection |
PA DOH; Leaf Data Systems ETS API-access notice (Jun 9, 2026); 28 Pa. Code §1141a.50 — Verified June 17, 2026.
Social Equity Compliance
Diversity-plan scoring mechanics, ongoing diversity-performance reporting obligations, and how Pennsylvania's approach compares to states with a dedicated equity license set-aside.
| Obligation | Frequency | Consequence of Non-Compliance |
|---|---|---|
| Diversity-plan performance reporting | Ongoing, per permit term | Considered at renewal/scoring review |
| Contracting-revenue tracking (diverse-certified vendors) | Ongoing | Required disclosure component |
| Employment diversity-goal tracking | Ongoing | Required disclosure component |
Unlike Florida's Pigford/Black Farmer set-aside MMTC track, Pennsylvania does not reserve a portion of its 25/50/10 permit caps for a defined equity applicant class. Diversity performance is instead folded into the standard competitive scoring rubric (worth roughly 10% of total points) and into ongoing reporting obligations for all permit holders. Premium and Elite CannBus members receive our full diversity-plan reporting template and scoring-rubric breakdown.
Enforcement & Penalties
Full DOH disciplinary process, the civil-penalty schedule, and the grounds for permit suspension or revocation.
| Step | What Happens | Your Response Window |
|---|---|---|
| Inspection / audit | DOH inspector identifies violation and documents it in a written report | — |
| Notice of violation | DOH issues written notice under 28 Pa. Code §1141a.47 | Varies by violation category |
| Civil fine | Up to $10,000 per violation, plus up to $1,000 per day for continuing violations | Per DOH notice terms |
| Suspension/Revocation | Grounds: failure to maintain effective diversion control, violation of the Act or regulations, violation of state/local law, falsified application information, failure to comply with an executed labor peace agreement, or failure to follow through on Community Impact commitments | Administrative hearing rights apply |
| Pending-hearing suspension | DOH may suspend or revoke a permit pending a hearing if it determines the health, safety, or welfare of the public, a patient, or a caregiver is at risk | Immediate |
Employment Law Intersections
Pennsylvania has a considerably more settled statutory framework than Florida's single-case landscape. Act 16 itself contains an explicit anti-discrimination provision protecting patient status — not conduct — making this one of the stronger employment-protection regimes among the medical-only states in this series.
| Permitted ✓ | Prohibited ✗ | Gray Area ⚠ |
|---|---|---|
| Drug-test applicants and employees for cannabis generally | Discharge, threaten, refuse to hire, or otherwise discriminate or retaliate against an employee or applicant solely because of their status as a certified patient — covering compensation, terms, conditions, location, or privileges of employment | Scope of "solely because of patient status" — courts have not extensively tested how this interacts with a positive workplace drug test that doesn't measure impairment |
| Enforce workplace safety rules and bar certified patients from specific high-risk duties while medicated | Bar a patient from operating/controlling chemicals requiring a federal/state permit, high-voltage electricity, or public utilities solely on the basis of patient status, absent the THC threshold below | Restrict patients with blood serum THC >10 ng/mL from those same high-risk duties — permitted, but field-testing/proof mechanics are not fully settled |
| Discipline for on-premises misuse or abuse of medical marijuana during work hours | Tolerate documented on-the-job impairment, regardless of patient status | Reach of the protection to off-duty conduct outside the listed high-risk-duty carve-outs |
| Apply stricter rules for safety-sensitive, DOT-regulated, or federal-contractor roles | Ignore federal drug-free-workplace obligations for federal contractors/DOT-regulated employers | — |
Because Act 16's anti-discrimination clause is written directly into the medical marijuana statute itself, Pennsylvania employers have considerably more textual guidance than Florida employers currently navigating a single, under-appeal trial court ruling. That said, PA's protection covers patient status only — it does not protect on-the-job impairment, on-premises possession, or use during work hours, all of which employers may still discipline.
Act 16 of 2016 (employment anti-discrimination provision); Pennsylvania Professional License Defense Lawyer summary — Verified June 17, 2026.
Advertising & Marketing Rules
28 Pa. Code §1141a.50 requires every MMO's promotional, advertising, and marketing materials to receive DOH pre-approval before use, and to conform to federal prescription-drug advertising standards under 21 CFR 202.1 — a stricter baseline than most medical-only states in this series.
| Permitted ✓ | Prohibited ✗ | Gray Area ⚠ |
|---|---|---|
| DOH-pre-approved promotional/marketing materials conforming to 21 CFR 202.1 standards | Advertising or marketing without prior DOH approval | Branded merchandise — permitted "in limited/controlled fashion" to patients, but the boundary against normalizing recreational use is not fully bright-lined |
| Limited, controlled branded merchandise distributed to patients | Targeting minors or making unsubstantiated health claims | Online/social content — DOH pre-approval applies, but no published review-turnaround timeline exists for digital content |
| Factual, DOH-approved patient-education materials | Billboards within 500 feet of a school; depicting consumption or promoting overconsumption; "safe because natural" or similar unsubstantiated safety claims | — |
| — | Free product samples; dispensaries advertising specific product prices in external marketing; testing labs advertising/marketing to the general public (may only market to grower/processors) | — |
28 Pa. Code §1141a.50 — Verified June 17, 2026.
Key Regulatory Resources & Contacts
Complete verified contact directory — direct DOH staff lines, ETS vendor support, and the DOH rulemaking/bill-tracking calendar for Q3 2026.
| Resource | URL | What It Covers |
|---|---|---|
| PA DOH — Office of Medical Marijuana | pa.gov/agencies/health | Patient/caregiver registry, MMO permitting, regulations |
| Pennsylvania Code (Title 28, Chs. 1141a/1151a) | pacodeandbulletin.gov | Full regulatory text |
| Pennsylvania State Police | psp.pa.gov | Background-check processing for principals/operators |
| Leaf Data Systems (ETS) | Statewide track-and-trace vendor | Seed-to-sale tracking, API access requests |
| PA Dept. of Revenue | revenue.pa.gov | CNIT, sales-tax exemption guidance |
| PA General Assembly | legis.state.pa.us | HB 1200, SB 120, SB 76 status tracking |
Recent Changes & What's Coming
Changed in the Last 24 Months
Gov. Shapiro signs legislation allowing PA medical marijuana organizations to claim a CNIT subtraction modification for federally-disallowed §280E expenses — the earliest state-level 280E fix of any state covered in this report series.
First-ever passage of a recreational marijuana bill by either chamber of the PA legislature (102-101, May 7, 2025); defeated in the Senate Law and Justice Committee roughly a week later. Pennsylvania remains medical-only.
Sens. Laughlin and Street introduce a privately-run adult-use retail alternative to HB 1200's state-store model; remains pending in committee.
The Bureau of Medical Marijuana simplifies the application/API form for third-party software integration with the Leaf Data Systems seed-to-sale platform.
Legislative Watch List
Would authorize privately-run adult-use retail stores instead of HB 1200's state-store model.
Introduced Jan 22, 2025; would allow patients 21+ to cultivate cannabis at home for personal use. No home-grow right exists today.
A 2025–2026 legislative push seeks to make the currently-temporary telehealth patient-certification/renewal allowance permanent in statute.
Federal Watch
A DOJ/DEA final order moved FDA-approved marijuana products and marijuana sold under a qualifying state medical marijuana program from Schedule I to Schedule III. Because Pennsylvania's program is 100% medical, federal 280E no longer applies to any PA MMO revenue — and it now stacks on top of the SB 1501 state-level fix already in place since October 2024. A separate expedited DEA hearing beginning June 29, 2026 will consider broader rescheduling; CannBus will alert immediately on any outcome.
Cannabis banking access remains limited nationwide; Pennsylvania MMOs continue to rely on cannabis-friendly credit unions and cash-management services.
Regulatory Calendar — Q3 2026
| Date / Period | Event | Relevant To |
|---|---|---|
| Ongoing | SB 120, SB 76, and telehealth-codification bills move through committee | All MMOs; prospective applicants |
| Per permit term | Diversity-plan performance reporting due | All permit holders |
| Per renewal cycle | Grower/Processor ($10,000) and Dispensary ($5,000, all locations) renewal fees due | Grower/Processors; Dispensaries |
| Sep 14, 2026 | This CannBus Legal Summary refreshes — updated with Q3 2026 developments | All CannBus members |
PA DOH bulletins; SB 1501; PA General Assembly bill tracking (2025–2026 session) — all verified June 17, 2026.
This summary is for informational purposes only and does not constitute legal advice. Laws and regulations change. Consult a licensed Pennsylvania attorney before making business or compliance decisions. CannBus is not a law firm and does not provide legal, financial, tax, or investment advice. All figures and rules reflect information verified as of June 17, 2026. Primary regulatory authority: Pennsylvania Department of Health, Office of Medical Marijuana — pa.gov/agencies/health. Next scheduled refresh: September 14, 2026.